
About a year ago, Anna DeLaRosby, PT, DPT, had a question for her former classmates from physical therapy school. A 2008 graduate of Clarke University, she had gone on to work at several different clinics and to become a physical therapy instructor herself.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Weighty Matters: Physical Therapy and GLP-1 Medications
What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.
Date: August 1, 2025
Contact: aptamag@apta.org
Content Type: Feature
Chris Hayhurst
You Might Also Like...
Article
APTA, NSCA Return-to-Play Summit Highlights Rehab, Performance
Physical therapists, physical therapist assistants, and strength and conditioning professionals came together Sept. 25-26 for the APTA & NSCA Return-to-Play
Feature
Neuroplasticity: The Science, the Spark, and the Everyday Work
Better brain, better outcomes. Why neuroplasticity matters in every physical therapy session.
Feature
How PT-PTA Teams Are Expanding Access to Care
Physical therapists and physical therapist assistants are redefining collaboration to improve access, efficiency, and patient outcomes.